Treatment Strategies for Chronic Pancreatitis (CP)
PharmaceuticalsChronic pancreatitis (CP) and autoimmune pancreatitis (AIP) are diseases with overlapping features, both requiring complex management strategies. CP is characterized by pancreatic exocrine insufficiency (PEI) and pain, with treatment focused on symptom ...
Katarzyna Tłustochowicz +3 more
doaj +1 more source
A condition closely mimicking IgG4-related disease despite the absence of serum IgG4 elevation and IgG4-positive plasma cell infiltration [PDF]
, 2016 We describe a 74-year-old Japanese man with systemic fibroinflammatory conditions closely resembling those of immunoglobulin G4-related disease (IgG4-RD).
Fujita Kentaro +12 more
core +1 more source
Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study [PDF]
, 2018 Glucocorticoids (GC) are effective for treating IgG4-related disease (IgG4-RD); however, relapse is often observed. We conducted a retrospective multicentre study to investigate risk factors in GC regimens associated with relapses of IgG4-RD. Data on 166
Chiba Tsutomu +26 more
core +2 more sources
Clinical Proteomics, 2019 Background Misdiagnosis of autoimmune pancreatitis (AIP) as pancreatic cancer (PDAC) or vice versa can cause dismal patents’ outcomes. Changes in IgG glycosylation are associated with cancers and autoimmune diseases.
Hsi-Chang Shih +7 more
doaj +1 more source
Autoimmune pancreatitis – the special form of chronic pancreatitis
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2013 The aim of review. To present features of clinical presentation, diagnostics and treatment of special form of chronic pancreatitis – autoimmune pancreatitis (AIP).Key points.
Ya. S. Tsimmerman
doaj
Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease [PDF]
, 2017 IgG4-related disease (IgG4-RD) is characterized by elevated serum IgG4 and marked infiltration of IgG4-positive cells in multiple organs. Interleukin-33 (IL-33) is a recently described cytokine that is secreted by damaged epithelial cells, macrophages ...
Furukawa Sachiko +14 more
core +1 more source
Gastroenterology Research and Practice, 2017 Introduction. Most investigations on autoimmune pancreatitis (AIP) were published on Asian cohorts while those on Caucasians are limited. However, there might be differences related to the origin. Patients and Methods.
Matthias Buechter +7 more
doaj +1 more source
Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report. [PDF]
Medicine (Baltimore), 2022 Iwamoto Y +7 more
europepmc +1 more source
DiagnosticsAutoimmune pancreatitis (AIP) is a unique form of chronic pancreatitis with a multifactorial pathogenesis. Historically, it has been classified as type 1 and type 2, according to its clinical and histological features. The diagnosis of AIP is challenging
Flavio Metelli +5 more
doaj +1 more source
BMC GastroenterologyBackground/Objectives Autoimmune pancreatitis (AIP) is a diagnosis-challenging disease that often mimics pancreatic malignancy. Pancreatic resection is considered to be a curative treatment for pancreatic ductal adenocarcinoma (PDAC).
Zain A. Karamya +7 more
doaj +1 more source